Taipei, Taiwan

Chih-Hsiung Hsieh

This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chih-Hsiung Hsieh. Retrieved from https://idiyas.com/inventor/chih-hsiung-hsieh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chih-Hsiung Hsieh and a Method for Applying Heat to Living Tissue.

Introduction

Chih-Hsiung Hsieh is an inventor associated with Taipei, Taiwan, and National Taiwan University. His listed patent concerns a method of applying heat to living tissue through controlled heating and cooling cycles.

Latest Patents

Hsieh is credited with 1 patent: “Method and Apparatus for Applying Heat to Living Tissue.” The invention describes treating at least part of living tissue in alternating high- and low-temperature steps. During the high-temperature step, the tissue is heated and maintained between 39°C and 46°C for no more than 30 minutes. The subsequent cooling period is limited to less than both the tissue’s natural cooling interval and the preceding heating period. The patent presents this approach as a way to selectively restore abnormal cells or induce their apoptosis while avoiding damage to normal cells.

Career Highlights

The available information associates Hsieh with National Taiwan University and identifies his work on controlled thermal treatment as a patent contribution. No further details about his role or career history are provided.

Collaborations

Chueh-Hsuan Lu and Yi-Kun Sun are listed as Hsieh’s coworkers. The available information does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Chih-Hsiung Hsieh’s listed patent focuses on carefully timed heating and cooling cycles intended to target abnormal tissue while protecting normal cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…